Evidence map›Paper›PMID 24914300›Full record

ArticlePharmacognosy magazine2014

Increased acetylcholine esterase activity produced by the administration of an aqueous extract of the seed kernel of Thevetia peruviana and its role on acute and subchronic intoxication in mice.

Rubén Marroquín-Segura, Ricardo Calvillo-Esparza, José Luis Alfredo Mora-Guevara, José Horacio Tovalín-Ahumada, Abigail Aguilar-Contreras, Vicente Jesús Hernández-Abad

Open access · bronzeAbstract read
In one paragraph

Article in Pharmacognosy magazine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rubén Marroquín-SeguraLaboratorio de Inmunología, Unidad Multidisciplinaria de Investigación Experimental, División de Estudios de Posgrado e Investigación, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México. Batalla de 5 de mayo s/n, Col. Ejército de Oriente, CP 09230, Mexico City, Mexico.
Ricardo Calvillo-EsparzaLaboratorio de Inmunología, Unidad Multidisciplinaria de Investigación Experimental, División de Estudios de Posgrado e Investigación, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México. Batalla de 5 de mayo s/n, Col. Ejército de Oriente, CP 09230, Mexico City, Mexico.
José Luis Alfredo Mora-GuevaraLaboratorio de Inmunología, Unidad Multidisciplinaria de Investigación Experimental, División de Estudios de Posgrado e Investigación, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México. Batalla de 5 de mayo s/n, Col. Ejército de Oriente, CP 09230, Mexico City, Mexico.
José Horacio Tovalín-AhumadaLaboratorio de Inmunología, Unidad Multidisciplinaria de Investigación Experimental, División de Estudios de Posgrado e Investigación, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México. Batalla de 5 de mayo s/n, Col. Ejército de Oriente, CP 09230, Mexico City, Mexico.
Abigail Aguilar-ContrerasHerbario de plantas medicinales, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social. Av. Cuauhtemoc 330, Col. Doctores, CP 06725, Mexico City, Mexico.
Vicente Jesús Hernández-AbadLaboratorio de Inmunología, Unidad Multidisciplinaria de Investigación Experimental, División de Estudios de Posgrado e Investigación, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México. Batalla de 5 de mayo s/n, Col. Ejército de Oriente, CP 09230, Mexico City, Mexico ; Laboratorio de Investigación Farmacéutica, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México. Batalla de 5 de mayo s/n, Col. Ejército de Oriente, CP 09230, Mexico City, Mexico.
Mexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe real mechanism for Thevetia peruviana poisoning remains unclear. Cholinergic activity is important for cardiac function regulation, however, the effect of T. peruviana on cholinergic activity is not well-known.

objectiveTo study the effect of the acute administration of an aqueous extract of the seed kernel of T. peruviana on the acetylcholine esterase (AChE) activity in CD1 mice as well its implications in the sub-chronic toxicity of the extract. MATERIALS AND

methodsA dose of 100 mg/kg of the extract was administered to CD1 mice and after 7 days, serum was obtained for ceruloplasmin (CP) quantitation and liver function tests. Another group of mice received a 50 mg/kg dose of the extract 3 times within 1 h time interval and AChE activity was determined for those animals. Heart tissue histological preparation was obtained from a group of mice that received a daily 50 mg/kg dose of the extract by a 30-days period.

resultsCP levels for the treated group were higher than those for the control group (Student's t-test, P ≤ 0.001). AChE activity in the treated group was significantly higher than the control group (Tukey test, control vs. T. peruviana, P ≤ 0.001). Heart tissue histological preparations showed leukocyte infiltrates and necrotic areas, consistent with infarcts.

conclusionThe increased levels of AChE and the hearth tissue infiltrative lesions induced by the aqueous seed kernel extract of T. peruviana explains in part the poisoning caused by this plant, which can be related to an inflammatory process.

Indexed as

Acetylcholine esteraseceruloplasminThevetia peruvianayellow oleander toxicity

Identifiers

PMID24914300
PMCPMC4047589
OpenAlexW1982840273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.